Skip to content

Clinical trials

Phase 3 Pain trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pain Phase: Phase 3 Country / region: Norway Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20061
20071
20081
20111
20141
20151
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daiichi Sankyo2
Sorlandet Hospital HF2
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Janssen Pharmaceutica N.V., Belgium1
Norwegian University of Science and Technology1
Oslo University Hospital1
Pfizer1
Ullevaal University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pain10
Fibromyalgia2
Neoplasms2
Adenoma1
Agnosia1
Cancer Pain1
Colorectal Neoplasms1
Constipation1
Hyperalgesia1
Intestinal Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.